Form 4 for ETN Eaton Corporation
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001104659-24-030108 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-01 | 2024-02-28 | ETN | Denk Peter | See Remarks below | A - Grant | $0.00 | +2,824 | 7,525 | +60% | $0 |
| DM | 2024-03-01 | 2024-02-29 | ETN | Denk Peter | See Remarks below | F - Tax | $286.94 | -2,215 | 7,083 | -24% | -$635.6K |
| DM | 2024-03-01 | 2024-02-29 | ETN | Denk Peter | See Remarks below | S - Sale+OE | $288.97 | -1,731 | 7,083 | -20% | -$500.2K |
| DM | 2024-03-01 | 2024-02-29 | ETN | Denk Peter | See Remarks below | M - OptEx | $103.64 | +3,923 | 8,064 | +95% | +$406.6K |
| DM | 2024-03-01 | 2024-02-29 | ETN | Denk Peter | See Remarks below | M - OptEx | $0.00 | -3,923 | 0 | -100% | $0 |
| DM | 2024-03-01 | 2024-02-28 | ETN | Denk Peter | See Remarks below | A - Grant | $0.00 | +3,550 | 2,700 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2024-02-28 | A | A | 2,824 | $0.00 | 7,525 | D | — | — | (F1) These shares were acquired upon the vesting of performance share awards. |
| 2 | Common | Ordinary Shares | 2024-02-29 | F | D | 1,179 | $285.16 | 6,346 | D | — | — | (F2) Represents shares withheld to cover taxes incurred in connection with the settlement of the performance share awards that vested February 28, 2024. |
| 3 | Common | Ordinary Shares | 2024-02-29 | S | D | 832 | $288.98 | 5,514 | D | — | — | (F3) Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $288.93 - $288.98. The reporting person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. |
| 4 | Common | Ordinary Shares | 2024-02-29 | M | A | 1,242 | $80.49 | 6,756 | D | — | — | |
| 5 | Common | Ordinary Shares | 2024-02-29 | F | D | 346 | $288.88 | 6,410 | D | — | — | |
| 6 | Common | Ordinary Shares | 2024-02-29 | M | A | 1,018 | $98.21 | 7,428 | D | — | — | |
| 7 | Common | Ordinary Shares | 2024-02-29 | S | D | 562 | $288.95 | 7,502 | D | — | — | |
| 8 | Common | Ordinary Shares | 2024-02-29 | M | A | 337 | $98.21 | 7,420 | D | — | — | |
| 9 | Common | Ordinary Shares | 2024-02-29 | S | D | 337 | $288.99 | 7,083 | D | — | — | |
| 10 | Common | Ordinary Shares | 2024-02-29 | M | A | 764 | $130.86 | 7,847 | D | — | — | |
| 11 | Common | Ordinary Shares | 2024-02-29 | F | D | 345 | $289.00 | 7,502 | D | — | — | |
| 12 | Common | Ordinary Shares | 2024-02-29 | M | A | 562 | $130.86 | 8,064 | D | — | — | |
| 13 | Common | Ordinary Shares | 2024-02-29 | F | D | 345 | $288.99 | 7,083 | D | — | — | |
| 14 | Derivative | Stock Option | 2024-02-29 | M | D | 764 | $0.00 | 3,136 | D | $130.86 · 2022-02-23 to 2031-02-23 | 764 Ordinary Shares | (F9) These stock options were granted on February 23, 2021 and became exercisable as follows: 33% on the first and second anniversary of the grant date and the remaining 34% on the third anniversary of the grant date. |
| 15 | Derivative | Stock Option | 2024-02-29 | M | D | 562 | $0.00 | 2,574 | D | $130.86 · 2022-02-23 to 2031-02-23 | 562 Ordinary Shares | (F9) These stock options were granted on February 23, 2021 and became exercisable as follows: 33% on the first and second anniversary of the grant date and the remaining 34% on the third anniversary of the grant date. |
| 16 | Derivative | Stock Option | 2024-02-29 | M | D | 337 | $0.00 | 0 | D | $98.21 · 2021-02-25 to 2030-02-25 | 337 Ordinary Shares | (F8) These stock options were granted on February 25, 2020 and were fully vested and exercisable. |
| 17 | Derivative | Stock Option | 2024-02-29 | M | D | 1,018 | $0.00 | 337 | D | $98.21 · 2021-02-25 to 2030-02-25 | 1,018 Ordinary Shares | (F8) These stock options were granted on February 25, 2020 and were fully vested and exercisable. |
| 18 | Derivative | Stock Option | 2024-02-29 | M | D | 1,242 | $0.00 | 0 | D | $80.49 · 2020-02-26 to 2029-02-26 | 1,242 Ordinary Shares | (F7) These stock options were granted on February 26, 2019 and were fully vested and exercisable. |
| 19 | Derivative | Restricted Stock Units | 2024-02-28 | A | A | 850 | $0.00 | 850 | D | $0.00 · 2025-02-28 to — | 850 Ordinary Shares | (F5) These restricted stock units were granted on February 28, 2024 and vest as follows: 33% on the first and second anniversary of the grant date and the remaining 34% on the third anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one ordinary share of the Issuer. (F6) This field is not applicable. |
| 20 | Derivative | Stock Option | 2024-02-28 | A | A | 2,700 | $0.00 | 2,700 | D | $286.96 · 2025-02-28 to 2034-02-28 | 2,700 Ordinary Shares | (F4) These stock options become exercisable as follows: 33% on the first and second anniversary of the date of the grant and the remaining 34% on the third anniversary of the date of the grant. |